An Electrochemical Immunoassay for HER2 Detection

被引:78
作者
Al-Khafaji, Q. A. M. [1 ,2 ,3 ]
Harris, M. [1 ,4 ]
Tombelli, S. [1 ]
Laschi, S. [1 ]
Turner, A. P. F. [4 ,5 ]
Mascini, M. [1 ]
Marrazza, G. [1 ]
机构
[1] Univ Florence, Dipartimento Chim Ugo Schiff, I-50121 Florence, Italy
[2] Al Nahrain Med Coll, Baghdad, Iraq
[3] Kamal Al Samaraei Hosp IVF & Infertil, Baghdad, Iraq
[4] Cranfield Univ, Cranfield MK43 0AL, Beds, England
[5] IFM Linkoping Univ, Biosensors & Bioelect Ctr, Linkoping, Sweden
关键词
HER2; Cancer marker; Magnetic beads; Immunoassay; BREAST-CANCER PATIENTS; EXTRACELLULAR DOMAIN; TUMOR-MARKERS; SERUM; PROTEIN; ASSAY; AMPLIFICATION; IMMUNOSENSOR; C-ERBB-2; SURVIVAL;
D O I
10.1002/elan.201100501
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this paper, a simple and sensitive approach for human epidermal growth factor receptor 2 (HER2) detection is presented, using antibody-functionalised magnetic beads coupled to screen-printed cells. The immunoassay is based on a sandwich format in which a primary monoclonal antibody anti-HER2 is coupled to protein A modified magnetic beads. The modified beads are then used to capture the protein from the sample solution and a sandwich assay is performed by adding a secondary monoclonal antibody anti-HER2 labelled with biotin. The enzyme alkaline phosphatase (AP) conjugated with streptavidin and its substrate (1-naphthyl-phosphate) are then used for the electrochemical detection by differential pulse voltammetry (DPV). The experimental conditions for the immunoassay were optimised. The performance of the assay in terms of sensitivity, reproducibility and selectivity has been studied in buffer and serum samples from hospital patients.
引用
收藏
页码:735 / 742
页数:8
相关论文
共 21 条
[1]   Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification [J].
Cayre, Anne ;
Mishellany, Florence ;
Lagarde, Nicole ;
Penault-Llorca, Fredirique .
BREAST CANCER RESEARCH, 2007, 9 (05) :R64
[2]   Improvement of analytical performances of a disposable electrochemical immunosensor by using magnetic beads [J].
Centi, S. ;
Laschi, S. ;
Mascini, M. .
TALANTA, 2007, 73 (02) :394-399
[3]   Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies [J].
Esteva, FJ ;
Cheli, CD ;
Fritsche, H ;
Fornier, M ;
Slamon, D ;
Thiel, RP ;
Luftner, D ;
Ghani, F .
BREAST CANCER RESEARCH, 2005, 7 (04) :R436-R443
[4]   Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor [J].
Gohring, John T. ;
Dale, Paul S. ;
Fan, Xudong .
SENSORS AND ACTUATORS B-CHEMICAL, 2010, 146 (01) :226-230
[5]   Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls [J].
Leyland-Jones, Brian ;
Smith, Brian R. .
LANCET ONCOLOGY, 2011, 12 (03) :286-295
[6]   Highly Sensitive Detection of HER2 Extracellular Domain in the Serum of Breast Cancer Patients by Piezoelectric Microcantilevers [J].
Loo, LiNa ;
Capobianco, Joseph A. ;
Wu, Wei ;
Gao, Xiaotong ;
Shih, Wan Y. ;
Shih, Wei-Heng ;
Pourrezaei, Kambiz ;
Robinson, Matthew K. ;
Adams, Gregory P. .
ANALYTICAL CHEMISTRY, 2011, 83 (09) :3392-3397
[7]   Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer [J].
Lottner, C ;
Schwarz, S ;
Diermeier, S ;
Hartmann, A ;
Knuechel, R ;
Hofstaedter, F ;
Brockhoff, G .
JOURNAL OF PATHOLOGY, 2005, 205 (05) :577-584
[8]   Evaluation of serum HER2 extracellular domain in early breast cancer patients:: correlation with clinicopathological parameters and survival [J].
Ludovini, V. ;
Gori, S. ;
Colozza, M. ;
Pistola, L. ;
Rulli, E. ;
Floriani, I. ;
Pacifico, E. ;
Tofanetti, F. R. ;
Sidoni, A. ;
Basurto, C. ;
Rulli, A. ;
Crino, L. .
ANNALS OF ONCOLOGY, 2008, 19 (05) :883-890
[9]   Surface plasmon resonance investigations of human epidermal growth factor receptor 2 [J].
Martin, V. S. ;
Sullivan, B. A. ;
Walker, K. ;
Hawk, H. ;
Sullivan, B. P. ;
Noe, L. J. .
APPLIED SPECTROSCOPY, 2006, 60 (09) :994-1003
[10]   Current technologies for HER2 testing in breast cancer [J].
Moelans, C. B. ;
de Weger, R. A. ;
Van der Wall, E. ;
van Diest, P. J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (03) :380-392